Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
At TheraMind, we are committed to employing the best technology available to diagnose and treat the neuropsychiatric medical disorders afflicting patients. We have affiliated with leading, nationally recognized, medical professionals in advanced neuro-imaging techniques and brain scan interpretation to assist our physicians in precisely diagnosing the extent of a given patient’s condition and, using the reports generated from such state-of-the-art diagnostics, target the exact portion(s) of the brain to receive TMS therapy and other targeted neurotherapy treatments. Such advanced imaging techniques are also used to monitor the progress of patients during the course of TMS therapy.
Our advanced diagnostics include the following: